The agreement would mark another step in the FTC’s effort to curb alleged anticompetitive practices in the insulin market.The CVS logo is displayed outside a CVS store in Los Angeles on Aug. 8, 2022. Mario Tama/Getty Images3/24/2026|Updated: 3/24/2026CVS Health’s Caremark has reached a settlement with the federal government in a lawsuit over insulin pricing, the latest of the “Big Three” prescription drug middlemen to strike such a deal.In a joint motion filed on Monday, CVS and the Federal Trade Commission (FTC) said they are seeking to remove the pharmacy company’s subsidiaries—prescription drug benefit manager Caremark and group purchasing organization Zinc—from the case while federal regulators finalize the settlement.
0.2
C
Ottawa
Tuesday, March 24, 2026
The Alliance Press is the world leader in online chained news and information and seeks to inform, engage and empower the world. We expose the information that wasn't known before or current events broadcast over the radio, television, online or in print media. Our content is now available through your mobile phone. No matter where your on-the-go lifestyle takes you, TAP brings the news directly to you.
More from CN
Contact
© The Alliance Media Group design by CODEUS